LABD - Direxion Daily S&P Biotech Bear 3X Shares

NYSEArca - NYSEArca Delayed Price. Currency in USD
19.07
-0.27 (-1.40%)
At close: 4:00PM EDT

19.05 -0.02 (-0.10%)
After hours: 4:38PM EDT

Stock chart is not supported by your current browser
Previous Close19.34
Open19.15
Bid0.00 x 1800
Ask0.00 x 3200
Day's Range18.66 - 19.41
52 Week Range16.42 - 62.25
Volume2,050,755
Avg. Volume3,037,225
Net Assets83.36M
NAV19.35
PE Ratio (TTM)N/A
Yield2.34%
YTD Return-54.15%
Beta (3Y Monthly)-4.67
Expense Ratio (net)1.11%
Inception Date2015-05-28
Trade prices are not sourced from all markets
  • Day Trading With Leveraged ETFs
    Investopedia2 months ago

    Day Trading With Leveraged ETFs

    Day trading using leveraged exchange traded funds (ETFs) is a high-risk undertaking but can return profit due to the volatile nature of the trade structure.

  • 5 Leveraged/Inverse ETFs That Are Up 20% Plus So Far in Q2
    Zacks2 months ago

    5 Leveraged/Inverse ETFs That Are Up 20% Plus So Far in Q2

    Volatility and uncertainty has resulted in a strong demand for leveraged and inverse-leveraged ETFs as these could fetch outsized returns on quick market turns in a short span.

  • TheStreet.com3 months ago

    In the Age of Algorithms

    The indices are well off the early lows Tuesday afternoon, but the question is whether they will manage another strong finish. The automatic buying of any dips smacks of compliancy, but in the age of algorithms, patterns tend to repeat much longer than they have in the past. In the 'old' days, the conventional wisdom was that when a pattern becomes common knowledge, it tended to stop working as traders anticipated it and undermined the movement.

  • Benzinga3 months ago

    Big Moves In Leveraged Biotech ETFs

    Leveraged biotechnology exchange traded funds (ETFs) are known to make big moves, but sometimes those moves are not always about price action. What Happened Entering Monday, the Direxion Daily S&P Biotech ...

  • Benzinga6 months ago

    This Biotech ETF Is Soaring, But A Bearish Friend Lures Traders

    Biotechnology stocks and the related exchange traded funds are off to sizzling starts in 2019. The soaring start to 2019 by the equal-weight S&P Biotechnology Select Industry Index is lifting the fortunes of the Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU). LABU, one of the largest leveraged biotechnology ETFs, is up more than 45 percent year-to-date, easily making it ne of Direxion's best-performing leveraged bullish ETFs in the month of January.

  • 7 Inverse ETFs That Soared More Than 70% in Q4
    Zacks7 months ago

    7 Inverse ETFs That Soared More Than 70% in Q4

    The myriad woes have resulted in huge demand for inverse or leveraged inverse ETFs for investors seeking to make big gains in a short span.

  • Benzinga8 months ago

    The Time Could Be Right For This Biotech ETF

    Biotechnology stocks and exchange traded funds have been slumping since last week's midterm elections and that could be an ominous sign. Ongoing weakness for the equal-weight S&P Biotechnology Select Industry Index benefits the Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD). LABD, one of the most heavily traded leveraged biotechnology ETFs, aims to deliver triple the daily inverse returns of the S&P Biotechnology Select Industry Index.

  • 7 Leveraged/Inverse ETFs Off to a Strong Start in October
    Zacks9 months ago

    7 Leveraged/Inverse ETFs Off to a Strong Start in October

    The leveraged and inverse leveraged space has grabbed investors' attention at the start of October in order to magnify returns on quick market turns.

  • How the Biotech Sector Has Fared this Year
    Market Realist11 months ago

    How the Biotech Sector Has Fared this Year

    Usually, when investors add biotechnology stocks to their portfolios, they feel confident about risk. When they want to reduce risk, biotech names are the first to go. LABU (3X Biotech Bull) and LABD (3X Biotech Bear) can help you stay risk-on or risk-off.